<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00683982</url>
  </required_header>
  <id_info>
    <org_study_id>PROT261179</org_study_id>
    <secondary_id>PROT261179B</secondary_id>
    <nct_id>NCT00683982</nct_id>
  </id_info>
  <brief_title>Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus</brief_title>
  <official_title>Nitazoxanide vs Probiotics in the Treatment of Acute Rotavirus Diarrhea in Children: A Randomized Single Blind Controlled Trial in Bolivian Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Pediatrico Albina de Patino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Pediatrico Albina de Patino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be
      clinically important in time of hospitalization and reduction of duration of diarrhea
      secondary to rotavirus?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing duration
      time of diarrhea in comparison to placebo in previous studies. In the current study, based in
      those results, we design a randomized single-blind controlled trial, in order to asses the
      effectiveness of nitazoxanide and probiotics in comparison with a control group
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of diarrhea</measure>
    <time_frame>Hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Diarrhea</condition>
  <condition>Rotavirus Infection</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive oral nitazoxanide preparation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive a mix combination of probiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This is the control group receiving only oral or systemic hydration solutions</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitazoxanide</intervention_name>
    <description>Nitazoxanide 15mg/Kg/day twice day for 3 days</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Noxom; Givotan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Probiotic mix preparation</intervention_name>
    <description>Probiotic preparation 1 gram twice a day for 5 days</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Probiotic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral hydration solutions</intervention_name>
    <description>Oral hydration solutions as needed</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Rehsal 60</other_name>
    <other_name>2.5% Glucosaline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive stool sample for rotavirus test

        Exclusion Criteria:

          -  Severe malnourishment

          -  Severe dehydration

          -  History of diarrhea more than 3 days previous hospitalization

          -  Use of antibiotics, probiotics or nitazoxanide 3 weeks before admission

          -  Systemic infections

          -  Severe chronic disease

          -  Mixed enteric infections besides rotavirus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos N Teran, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Centro Pediatrico Albina Patiño</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Pediatrico Albina Patiño</name>
      <address>
        <city>Cochabamba</city>
        <zip>591</zip>
        <country>Bolivia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bolivia</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2008</study_first_submitted>
  <study_first_submitted_qc>May 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2008</study_first_posted>
  <last_update_submitted>May 23, 2008</last_update_submitted>
  <last_update_submitted_qc>May 23, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2008</last_update_posted>
  <responsible_party>
    <name_title>Carlos Teran Escalera/Jefe de Comite de Investigacion</name_title>
    <organization>Centro Pediatrico Albina Patiño</organization>
  </responsible_party>
  <keyword>nitazoxanide</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Diarrhea</keyword>
  <keyword>Rotavirus</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Rotavirus Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Nitazoxanide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

